|Files in This Item:|
There are no files associated with this item.
|Title: ||Tinzaparin is safe and effective in the management of hemodialysis catheter thrombosis.|
|Affiliation: ||Department of Nephrology, The Children's University Hospital, Dublin, Ireland. CathyQuinlan@mac.com|
|Citation: ||Tinzaparin is safe and effective in the management of hemodialysis catheter thrombosis., 58 (3):288-90 ASAIO J.|
|Journal: ||ASAIO journal (American Society for Artificial Internal Organs : 1992)|
|Issue Date: ||27-Aug-2012 |
|PubMed ID: ||22456106|
|Abstract: ||Children on hemodialysis are at increased risk of thrombosis, especially when dialyzed via a central venous catheter (CVC); there are limited published data regarding the safety and efficacy of tinzaparin in this group. We conducted a retrospective chart review of all children in the National Pediatric Hemodialysis Centre for Ireland diagnosed with a CVC thrombus and treated with subcutaneous tinzaparin over a 10 year period. Seven children were treated with subcutaneous tinzaparin for 10 CVC thrombi. Tinzaparin was commenced at 175 IU/kg/day and the dose was titrated by measuring anti-factor Xa levels, aiming for levels of 0.3-1.0 IU/ml. Treatment was continued until resolution of the CVC thrombus. Restoration of normal flows during dialysis occurred within 3 days in all patients. There were no episodes of bleeding and all children tolerated the treatment well.|
Catheterization, Central Venous
|Appears in Collections: ||Temple Street Hospital|
All Items in LENUS are protected by copyright, with all rights reserved, unless otherwise indicated.